These findings suggest that both the absolute and relative levels of CD16+CD56+CD3− NK cells prior to treatment may serve as useful immunological biomarkers for predicting response to LD-RTX alone or in combination with THD in steroid-resistant or steroid-refractory ITP (Figure 2). This evidence concerns the gene NCAM1 and autoimmune thrombocytopenic purpura.